•   
  •   

Money Supply of 100 UK medicines to be disrupted, warns EMA

04:35  12 july  2018
04:35  12 july  2018 Source:   msn.com

The NHS is preparing to stockpile medicine in case of a no deal Brexit, health service boss admits

  The NHS is preparing to stockpile medicine in case of a no deal Brexit, health service boss admits NHS Chief Executive Simon Stevens (pictured) said there was 'immediate planning' around the Department for Health and in hospitals about 'securing medical supply' under different scenarios.Simon Stevens said there was 'immediate planning' around the Department for Health and in hospitals about 'securing medical supply' under different scenarios.

About 45m packs of medicines are supplied from the UK to other European countries each month, while more than 37m packs come from Europe to the UK . David Prior, life sciences minister until October, said that it would be “fantastic” if the UK stayed in the EMA , warning of a negative impact on

The European Medicines Agency ( EMA ) is a European Union agency for the evaluation of medicinal products. ^ "Brexit: People will die because of plans to set up UK -only drug regulator, cancer specialist warns ". Euratom Supply Agency.

The supply of more than 100 medicines manufactured solely in the UK is at risk of disruption post-Brexit because necessary work to ensure they can be licensed and released for sale in mainland Europe has not yet been carried out.

The assessment has come from the European Medicines Agency, the regulator, following a survey of action taken by pharmaceutical companies to safeguard supplies of almost 700 products whose marketing authorisations were granted in the UK.

a store shelf filled with books: Pfizer And AstraZeneca's Billion Dollar Battle...Boxes containing various pharmaceutical products are seen on display in the pharmacy department of a drugstore in London, U.K., on Friday, May 2, 2014. AstraZeneca Plc rejected Pfizer Inc.'s sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to recognize the value of the promising experimental medicines under development by the U.K.'s second-biggest drugmaker. Photographer: Chris Ratcliffe/Bloomberg © Bloomberg Pfizer And AstraZeneca's Billion Dollar Battle...Boxes containing various pharmaceutical products are seen on display in the pharmacy department of a drugstore in London, U.K., on Friday, May 2, 2014. AstraZeneca Plc rejected Pfizer Inc.'s sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to recognize the value of the promising experimental medicines under development by the U.K.'s second-biggest drugmaker. Photographer: Chris Ratcliffe/Bloomberg

In order to ensure that the medicines can continue to be available throughout Europe once Britain leaves the EU, this authorisation may need to be “transferred to a legal entity established in the European Economic Area”, said the EMA.

UK’s renters face squeeze as tax reforms shrink supply of homes

  UK’s renters face squeeze as tax reforms shrink supply of homes UK’s renters face squeeze as tax reforms shrink supply of homesLetting agents have reported a drop in the number of new instructions on properties to let for 21 consecutive months, according to the latest monthly residential market survey by the Royal Institute for Chartered Surveyors.

European Medicines Agency ( EMA ) is a government entity that promotes access to and approval of medications in European countries. Stock Simulator. Trade with a starting balance of $ 100 ,000 and zero risk! My Portfolios.

Brexit will put British patients at the “back of the queue” for vital new drugs, the Government has been warned – forcing them to wait up to two years longer A medicines regulator has raised the alarm over a likely decision to pull out of the European Medicines Agency ( EMA ), as well as the EU itself. ealth

Other changes that may be necessary include transferring some operations to monitor drug safety, so-called “pharmacovigilance”, to a location in the EEA, “as well as adaptations to their logistics, manufacturing sites, supply chains and contracts”.

Each month, the UK supplies 45m packs of medicine to the EU and European Economic Area countries.

The regulator said it was now “looking in detail at those medicines where there are risks of supply shortages and will assess how critical these are”.

It said that marketing authorisation holders for more than half of the 694 products concerned are on track with their regulatory planning, ensuring the authorisations will remain valid once the UK leaves the European Union.

However, for 108 medicines — 88 human products and 20 veterinary products — “there are serious concerns that the necessary actions will not be carried out in time”, it said.

EU states told to step up 'no deal' Brexit preparations

  EU states told to step up 'no deal' Brexit preparations EU member states have been told to step up their preparations for a possible "no deal" Brexit.The European Commission said "everyone must now step up preparations for all scenarios and take responsibility for their specific situation" ahead of Britain's official exit day of 30 March 2019.

Customs delays. The committee said there was a "striking" contrast between the government's apparent confidence over the risk of disruption to food supplies and The committee warned the UK 's ports would be clogged up if EU goods were subject to the same border checks as other imported produce.

The Independent Books. Puzzles. indy 100 . Apps. Drug giants have told of “significant disruption to the supply chain for medicines ” and that customs delays would damage “time and temperature sensitive” materials, without a Disruption to medicines means UK 'must stay under EU regulation'.

For 10 per cent of the products included in the survey, EMA received no feedback from companies.

The aim of the survey, which was launched in January this year, was to identify medicines that are potentially at risk of supply shortages “and to obtain information on the timelines for submission of the necessary regulatory changes”, said the EMA.

  Supply of 100 UK medicines to be disrupted, warns EMA © AP

The survey was sent to marketing authorisation holders of 661 human, and 33 veterinary, products who are located in the UK or who have “quality control, batch release and/or import or manufacturing sites”, or a qualified person for pharmacoviligance in the UK.

The EMA said it “urges those companies who have not yet informed EMA of their Brexit preparedness plans to do so as soon as possible to mitigate any risks to the continuous supply of medicines for human and veterinary use within the EU”.

EU issues stark warning over the consequences of a no-deal Brexit .
<p>The once-unthinkable prospect of a no-deal Brexit has become much more realistic in recent weeks as Theresa May struggles to negotiate with her own government.</p>

—   Share news in the SOC. Networks

Topical videos:

This is interesting!